Polar Capital’s Edwards Lifesciences EW Stock Holding History

Polar Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-788,529	Closed	-$57.8M	–	289
2019 Q3	$57.8M	Buy	+788,529	New	+$55.4M	0.52%	58
2019 Q2	–	Sell	-645,000	Closed	-$41.1M	–	288
2019 Q1	$41.1M	Buy	+645,000	New	+$36.8M	0.38%	87
2018 Q3	–	Sell	-848,514	Closed	-$41.2K	–	278
2018 Q2	$41.2K	Sell	848,514 -306,486	-27%	-$14.3M	0.25%	93
2018 Q1	$53.7M	Hold	1,155,000	–	–	0.54%	60
2017 Q4	$43.4M	Buy	+1,155,000	New	+$42.4M	0.45%	68
2017 Q3	–	Sell	-690,000	Closed	-$27.2M	–	243
2017 Q2	$27.2M	Buy	+690,000	New	+$25.2M	0.37%	99
2016 Q4	–	Sell	-728,790	Closed	-$29.3M	–	260
2016 Q3	$29.3M	Buy	+728,790	New	+$27.4M	0.51%	53
2015 Q3	–	Sell	-1,320,000	Closed	-$31.3M	–	276
2015 Q2	$31.3M	Buy	1,320,000 +120,000	+10%	+$2.71M	0.6%	50
2015 Q1	$28.5M	Buy	+1,200,000	New	+$26.9M	0.54%	58

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Polar Capital's EW Position: Q4 2019 in Review

Polar Capital sold out of Edwards Lifesciences (EW) in Q4 2019, closing a stake of 788,529 shares — an estimated $57.8M sold.

Polar Capital first reported a position in EW in Q1 2015 and held it in 9 quarters. The position peaked at $57.8M in Q3 2019. 1,092 funds tracked by Wall St. Rank hold EW as of Q4 2019.

Polar Capital reported no remaining Edwards Lifesciences position as of Q4 2019 after selling out during the quarter.
Polar Capital sold 788,529 Edwards Lifesciences shares in Q4 2019, an estimated $57.8M.
Polar Capital first reported a position in Edwards Lifesciences in Q1 2015 and held it in 9 quarters.
Polar Capital's Edwards Lifesciences position peaked at $57.8M in Q3 2019.
1,092 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2019.

Based on Polar Capital's 13F filing for Q4 2019, filed 14 Feb 2020.